Table 2.
Baseline clinical, laboratory results, and followup outcome characteristics of PLWH at Nekemte referral hospital and Nekemte Health center followed from September 2009-September 2012.
| Variables(n=600) | Category | Cohort group | Total n (%) | |
| IPT n (%) cohort | Non-IPT cohort n (%) | |||
|
| ||||
| CD4 | <=200 | 20(10%) | 68(11.33%) | 88(14.66%) |
| 201-350 | 64(32%) | 119(29.75%) | 183(30.5%) | |
| 351-500 | 52(26%) | 97(24.25%) | 149(24.83%) | |
| >500 | 64(32%) | 116(29%) | 180(30%) | |
|
| ||||
| BMI | >=18.5 | 127(63.5%) | 229(57.25%) | 356(59.33%) |
| <18.5 | 73(36.5%) | 171(42.75%) | 244(40.66%) | |
|
| ||||
| Weight | <=50 | 85(42.5%) | 177(44.25%) | 266(40.66%) |
| >50 | 115(57.5%) | 223(55.75%) | 338(56.33%) | |
|
| ||||
| WHO Stage | I/II | 164(82%) | 294(73.5%) | 458(76.33%) |
| III/IV | 36(18%) | 106(26.5%) | 142(23.66%) | |
|
| ||||
| Functional Status | Working | 169(84.5%) | 348(87%) | 517(86.16%) |
| Ambulatory/Bedridden | 29(14.5%) | 43(10.75%) | 72(18%) | |
|
| ||||
| Opportunistic Infection | Yes | 45(22.5%) | 80(20%) | 125(20.83%) |
| No | 155(77.5%) | 320(80%) | 475(79.16%) | |
|
| ||||
| Cotrimoxazole Treatment | Yes | 142(71%) | 287(71.75%) | 429(71.5%) |
| No | 58(29%) | 113(28.25%) | 171(28.5%) | |
|
| ||||
| Previous TB | Yes | 45(22.5%) | 80(20%) | 125(20.83%) |
|
| ||||
| No | 155(77.5%) | 320(80%) | 475(79.16%) | |
|
| ||||
| Outcome status | TB | 11(5.5%) | 42(10.5%) | 53(8.83%) |
| Censored | 189(94.5%) | 358(89.5%) | 547(91.16%) | |
Censored: loss to followup, death, transferred out, started IPT (for non-IPT).